1 – 2 of 2
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Endogenous vasopressin and vasopressin receptor 2 in bladder as anti-diuretic / anti-spasmodic targets for the treatment of multifactorial nocturia
- Contribution to journal › Article
- 2022
-
Mark
Benign prostatic hyperplasia/obstruction ameliorated using a soluble guanylate cyclase activator
- Contribution to journal › Article
